4Pritzker KH. Cancer biomarkers : easier said than done. Clin Chem, 2002,48: 1147- 1150.
5Fleisher M, Dnistrian AM, Sturgeon CM, et al. Practice guidelines and recommendations for use tumor markers in the clinic. Washington DC: AACC Press,2002.20-25
7Lakhani SR, Ashworth A. Microarray and histo-pathological analysis of tumours:the future and the past? Nature Rev Cancer, 2001,1:151-157.
8Yu H, Diamandis EP, Levesque M, et al. Prostate specific antigen in breast cancer benign breast disease and normal breast tissue. Breast Cancer Res Treat, 1996,40:171- 178.
9Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003,3:267-275.
10Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer, 2002, 2:210-219.
9Carpelan-Holmstrom M,Louhimo J,Stenman U H,et al.CEA,CA19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers[J].Anti-cancer Res,2002,22(4):2311-2316.
10Nazli O,Bozdag A D,Tansug T,et al.The diagnostic importance of CEA and CA19-9 for the early diagnosis of pancreatic carcinoma[J].Hepatogastro-enterology,2000,47(36):1750-1752.
